Assessment of systolic dyssynchrony for cardiac resynchronization therapy is not clinically useful

Circulation

Volumn 123, Issue 6, 2011, Pages 656-662

  Sung, Raphael K ^a   Foster, Elyse ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CLINICAL ASSESSMENT; COMPARATIVE STUDY; DEATH; DEFIBRILLATOR; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FOLLOW UP; HEART FAILURE; HEART FUNCTION TEST; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEMODYNAMICS; HOSPITALIZATION; HUMAN; MEDICAL SOCIETY; MORBIDITY; MORTALITY; PRIORITY JOURNAL; Q WAVE; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY AND SPECIFICITY; SYSTOLIC DYSSYNCHRONY; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TISSUE DOPPLER IMAGING; TREATMENT RESPONSE;

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIALS AS TOPIC; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 79951600478     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.954420     Document Type: Article

References (63)

1. Auricchio A, Stellbrink C, Butter C, Sack S, Vogt J, Misier AR, Bocker D, Block M, Kirkels JH, Kramer A, Huvelle E. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol. 2003;42:2109-2116. (Pubitemid 37549894)
2. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344: 873-880. (Pubitemid 32224395)
3. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346: 1845-1853. (Pubitemid 34603028)
4. Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, Boehmer JP, Higginbotham MB, De Marco T, Foster E, Yong PG. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol. 2003;42:1454-1459. (Pubitemid 37267289)
5. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM, for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
6. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappen-berger L, Tavazzi L; Cardiac Resynchronization-Heart Failure Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-1549. (Pubitemid 40517094)
7. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005; 112:e154-e235.
8. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA, Gavazzi A, Haverich A, Hoes A, Jaarsma T, Korewicki J, Levy S, Linde C, Lopez-Sendon JL, Nieminen MS, Pierard L, Remme WJ. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115-1140.
9. Arnold JM, Liu P, Demers C, Dorian P, Giannetti N, Haddad H, Heckman GA, Howlett JG, Ignaszewski A, Johnstone DE, Jong P, McKelvie RS, Moe GW, Parker JD, Rao V, Ross HJ, Sequeira EJ, Svendsen AM, Teo K, Tsuyuki RT, White M. Canadian Cardiovascular Society Consensus Conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol. 2006;22:23-45.
10. Kronborg MB, Mortensen PT, Kirkfeldt RE, Nielsen JC. Very long term follow-up of cardiac resynchronization therapy: clinical outcome and predictors of mortality. Eur J Heart Fail. 2008;10:796-801.
11. Ypenburg C, van Bommel RJ, Borleffs CJ, Bleeker GB, Boersma E, Schalij MJ, Bax JJ. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol. 2009;53:483-490.
12. Yu CM, Bleeker GB, Fung JW, Schalij MJ, Zhang Q, van der Wall EE, Chan YS, Kong SL, Bax JJ. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation. 2005;112:1580-1586. (Pubitemid 41324519)
13. Cha YM, Rea RF, Wang M, Shen WK, Asirvatham SJ, Friedman PA, Munger TM, Espinosa RE, Hodge DO, Hayes DL, Redfield MM. Response to cardiac resynchronization therapy predicts survival in heart failure: a single-center experience. J Cardiovasc Electrophysiol. 2007; 18:1015-1019. (Pubitemid 47416574)
14. Cleland J, Freemantle N, Ghio S, Fruhwald F, Shankar A, Marijanowski M, Verboven Y, Tavazzi L. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial. J Am Coll Cardiol. 2008;52:438-445. (Pubitemid 352040815)
15. Woo GW, Petersen-Stejskal S, Johnson JW, Conti JB, Aranda JA Jr, Curtis AB. Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: analysis of the MIRACLE study. J Intervent Cardiac Electrophysiol. 2005;12:107-113. (Pubitemid 40386293)
16. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappen-berger L, Tavazzi L. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the Cardiac Resynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J. 2006;27:1928-1932. (Pubitemid 44297365)
17. Solomon S, Foster E, Bourgoun M, Shah A, Viloria E, Brown M, Hall WJ, Pfeffer MA, Moss AJ. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: MADIT-CRT. Circulation. 2010;122:985-992.
18. Anderson LJ, Miyazaki C, Sutherland GR, Oh JK. Patient selection and echocardiographic assessment of dyssynchrony in cardiac resynchroni-zation therapy. Circulation. 2008;117:2009-2023. (Pubitemid 351543477)
19. Hawkins NM, Petrie MC, Burgess MI, McMurray JJ. Selecting patients for cardiac resynchronization therapy: the fallacy of echocardiographic dyssynchrony. J Am Coll Cardiol. 2009;53:1944-1959.
20. Bleeker GB, Schalij MJ, Boersma E, Holman ER, Steendijk P, van der Wall EE, Bax JJ. Relative merits of M-mode echocardiography and tissue Doppler imaging for prediction of response to cardiac resynchronization therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2007;99:68-74. (Pubitemid 44969346)
21. Soliman OI, Theuns DA, Geleijnse ML, Anwar AM, Nemes A, Caliskan K, Vletter WB, Jordaens LJ, Cate FJ. Spectral pulsed-wave tissue Dopp-ler imaging lateral-to-septal delay fails to predict clinical or echocardio-graphic outcome after cardiac resynchronization therapy. Europace. 2007;9:113-118. (Pubitemid 46237974)
22. Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, van der Wall EE, Schalij MJ. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44:1834-1840. (Pubitemid 39424084)
23. Van de Veire NR, Bleeker GB, De Sutter J, Ypenburg C, Holman ER, van der Wall EE, Schalij MJ, Bax JJ. Tissue synchronisation imaging accurately measures left ventricular dyssynchrony and predicts response to cardiac resynchronisation therapy. Heart. 2007;93:1034-1039. (Pubitemid 47310976)
24. Delgado V, Ypenburg C, van Bommel RJ, Tops LF, Mollema SA, Marsan NA, Bleeker GB, Schalij MJ, Bax JJ. Assessment of left ventricular dyssynchrony by speckle tracking strain imaging comparison between longitudinal, circumferential, and radial strain in cardiac resynchroni-zation therapy. J Am Coll Cardiol. 2008;51:1944-1952. (Pubitemid 351636442)
25. Kaufman CL, Kaiser DR, Burns KV, Kelly AS, Bank AJ. Multi-plane mechanical dyssynchrony in cardiac resynchronization therapy. Clin Cardiol. 2010;33:E31-E38.
26. Marsan NA, Bleeker GB, Ypenburg C, Van Bommel RJ, Ghio S, Van de Veire NR, Delgado V, Holman ER, van der Wall EE, Schalij MJ, Bax JJ. Real-time three-dimensional echocardiography as a novel approach to assess left ventricular and left atrium reverse remodeling and to predict response to cardiac resynchronization therapy. Heart Rhythm. 2008;5: 1257-1264.
27. Soliman OI, Geleijnse ML, Theuns DA, van Dalen BM, Vletter WB, Jordaens LJ, Metawei AK, Al-Amin AM, ten Cate FJ. Usefulness of left ventricular systolic dyssynchrony by real-time three-dimensional echo-cardiography to predict long-term response to cardiac resynchronization therapy. Am J Cardiol. 2009;103:1586-1591.
28. Jansen AH, Bracke F, van Dantzig JM, Meijer A, Korsten EH, Peels KH, van Hemel NM. Optimization of pulsed wave tissue Doppler to predict left ventricular reverse remodeling after cardiac resynchronization therapy. J Am Soc Echocardiogr. 2006;19:185-191. (Pubitemid 43187162)
29. Yu CM, Fung JW, Zhang Q, Chan CK, Chan YS, Lin H, Kum LC, Kong SL, Zhang Y, Sanderson JE. Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation. 2004;110:66-73. (Pubitemid 38880135)
30. Yu CM, Gorcsan J III, Bleeker GB, Zhang Q, Schalij MJ, Suffoletto MS, Fung JW, Schwartzman D, Chan YS, Tanabe M, Bax JJ. Usefulness of tissue Doppler velocity and strain dyssynchrony for predicting left ventricular reverse remodeling response after cardiac resynchronization therapy. Am J Cardiol. 2007;100:1263-1270. (Pubitemid 47498285)
31. Yu CM, Zhang Q, Chan YS, Chan CK, Yip GW, Kum LC, Wu EB, Lee PW, Lam YY, Chan S, Fung JW. Tissue Doppler velocity is superior to displacement and strain mapping in predicting left ventricular reverse remodelling response after cardiac resynchronisation therapy. Heart. 2006;92:1452-1456. (Pubitemid 44578840)
32. Mele D, Toselli T, Capasso F, Stabile G, Piacenti M, Piepoli M, Giatti S, Klersy C, Sallusti L, Ferrari R. Comparison of myocardial deformation and velocity dyssynchrony for identification of responders to cardiac resynchronization therapy. Eur J Heart Fail. 2009;11:391-399.
33. Porciani MC, Lilli A, Macioce R, Cappelli F, Demarchi G, Pappone A, Ricciardi G, Padeletti L. Utility of a new left ventricular asynchrony index as a predictor of reverse remodelling after cardiac resynchroni-zation therapy. Eur Heart J. 2006;27:1818-1823. (Pubitemid 44297388)
34. Lim P, Buakhamsri A, Popovic ZB, Greenberg NL, Patel D, Thomas JD, Grimm RA. Longitudinal strain delay index by speckle tracking imaging: a new marker of response to cardiac resynchronization therapy. Circulation. 2008;118:1130-1137.
35. Yu CM, Zhang Q, Fung JW, Chan HC, Chan YS, Yip GW, Kong SL, Lin H, Zhang Y, Sanderson JE. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging. J Am Coll Cardiol. 2005;45:677-684. (Pubitemid 40278965)
36. Gorcsan J III, Tanabe M, Bleeker GB, Suffoletto MS, Thomas NC, Saba S, Tops LF, Schalij MJ, Bax JJ. Combined longitudinal and radial dys-synchrony predicts ventricular response after resynchronization therapy. J Am Coll Cardiol. 2007;50:1476-1483. (Pubitemid 47494594)
37. Achilli A, Sassara M, Ficili S, Pontillo D, Achilli P, Alessi C, De Spirito S, Guerra R, Patruno N, Serra F. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS. J Am Coll Cardiol. 2003;42:2117-2124. (Pubitemid 37549895)
38. Yu CM, Chan YS, Zhang Q, Yip GW, Chan CK, Kum LC, Wu L, Lee AP, Lam YY, Fung JW. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol. 2006;48: 2251-2257. (Pubitemid 44873057)
39. Bleeker GB, Holman ER, Steendijk P, Boersma E, van der Wall EE, Schalij MJ, Bax JJ. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol. 2006;48:2243-2250. (Pubitemid 44873059)
40. Leon AR NI, Herrman K, Stucky M, Galle E, Donahue T. Chronic evaluation of CRT in narrow QRS patients with mechanical dyssyn-chrony from a multi-center study: ESTEEM-CRT. Heart Rhythm. 2008; 5:S23-S24.
41. Beshai JF, Grimm RA, Nagueh SF, Baker JH II, Beau SL, Greenberg SM, Pires LA, Tchou PJ. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med. 2007;357:2461-2471. (Pubitemid 350272785)
42. Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsan J III, St John Sutton M, De Sutter J, Murillo J. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008;117:2608-2616.
43. Macias A, Gavira JJ, Castano S, Alegria E, Garcia-Bolao I. Left ventricular pacing site in cardiac resynchronization therapy: clinical follow-up and predictors of failed lateral implant. Eur J Heart Fail. 2008;10: 421-427. (Pubitemid 351458765)
44. Rossillo A, Verma A, Saad EB, Corrado A, Gasparini G, Marrouche NF, Golshayan AR, McCurdy R, Bhargava M, Khaykin Y, Burkhardt JD, Martin DO, Wilkoff BL, Saliba WI, Schweikert RA, Raviele A, Natale A. Impact of coronary sinus lead position on biventricular pacing: mortality and echocardiographic evaluation during long-term follow-up. J Car-diovasc Electrophysiol. 2004;15:1120-1125. (Pubitemid 39426037)
45. Khan FZ, Virdee MS, Fynn SP, Dutka DP. Left ventricular lead placement in cardiac resynchronization therapy: where and how? Europace. 2009;11:554-561.
46. Ansalone G, Giannantoni P, Ricci R, Trambaiolo P, Fedele F, Santini M. Doppler myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving biventricular pacing. J Am Coll Cardiol. 2002;39: 489-499. (Pubitemid 34117507)
47. Murphy RT, Sigurdsson G, Mulamalla S, Agler D, Popovic ZB, Starling RC, Wilkoff BL, Thomas JD, Grimm RA. Tissue synchronization imaging and optimal left ventricular pacing site in cardiac resynchroni-zation therapy. Am J Cardiol. 2006;97:1615-1621. (Pubitemid 43737035)
48. Becker M, Hoffmann R, Schmitz F, Hundemer A, Kuhl H, Schauerte P, Kelm M, Franke A. Relation of optimal lead positioning as defined by three-dimensional echocardiography to long-term benefit of cardiac resynchronization. Am J Cardiol. 2007;100:1671-1676. (Pubitemid 350122330)
49. Becker M, Franke A, Breithardt OA, Ocklenburg C, Kaminski T, Kramann R, Knackstedt C, Stellbrink C, Hanrath P, Schauerte P, Hoffmann R. Impact of left ventricular lead position on the efficacy of cardiac resynchronisation therapy: a two-dimensional strain echocardiog-raphy study. Heart. 2007;93:1197-1203. (Pubitemid 47492902)
50. Adelstein EC, Saba S. Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy. Am Heart J. 2007;153:105-112. (Pubitemid 44880886)
51. Ypenburg C, Schalij MJ, Bleeker GB, Steendijk P, Boersma E, Dibbets-Schneider P, Stokkel MP, van der Wall EE, Bax JJ. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J. 2007;28:33-41. (Pubitemid 46134955)
52. Mele D, Agricola E, Galderisi M, Rigo F, Citro R, Dal Monte A, Della Valentina P, Calabrese A, Ferrari R. Echocardiographic myocardial scar burden predicts response to cardiac resynchronization therapy in ischemic heart failure. J Am Soc Echocardiogr. 2009;22:702-708.
53. Ypenburg C, Roes SD, Bleeker GB, Kaandorp TA, de Roos A, Schalij MJ, van der Wall EE, Bax JJ. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am J Cardiol. 2007;99:657-660.
54. van Gelder BM, Meijer A, Bracke FA. Timing of the left ventricular electrogram and acute hemodynamic changes during implant of cardiac resynchronization therapy devices. Pacing Clin Electrophysiol. 2009; 32(suppl 1):S94-S97.
55. Stanton T, Hawkins NM, Hogg KJ, Goodfield NE, Petrie MC, McMurray JJ. How should we optimize cardiac resynchronization therapy? Eur Heart J. 2008;29:2458-2472.
56. Barold SS, Ilercil A, Herweg B. Echocardiographic optimization of the atrioventricular and interventricular intervals during cardiac resynchroni-zation. Europace. 2008;10(suppl 3):iii88-iii95.
57. Waggoner AD, de las Fuentes L, Davila-Roman VG. Doppler echocardio-graphic methods for optimization of the atrioventricular delay during cardiac resynchronization therapy. Echocardiography. 2008;25:1047-1055.
58. Yu CM, Wing-Hong Fung J, Zhang Q, Sanderson JE. Understanding nonresponders of cardiac resynchronization therapy: current and future perspectives. J Cardiovasc Electrophysiol. 2005;16:1117-1124.
59. Leclercq C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol. 2002;39: 194-201. (Pubitemid 34084621)
60. Jansen AH, Bracke FA, van Dantzig JM, Meijer A, van der Voort PH, Aarnoudse W, van Gelder BM, Peels KH. Correlation of echo-Doppler optimization of atrioventricular delay in cardiac resynchronization therapy with invasive hemodynamics in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2006;97:552-557. (Pubitemid 43190049)
61. Stein KM, Ellenbogen KA, Gold MR, Lemke B, Lozano IF, Mittal S, Spinale FG, Van Eyk JE, Waggoner AD, Meyer TE. SmartDelay determined AV optimization: a comparison of AV delay methods used in cardiac resynchronization therapy (SMART-AV): rationale and design. Pacing Clin Electrophysiol. 2010;33:54-63.
62. Nagueh SF. Mechanical dyssynchrony in congestive heart failure: diagnostic and therapeutic implications. J Am Coll Cardiol. 2008;51:18-22.
63. Abraham J, Abraham TP. Is echocardiographic assessment of dyssyn-chrony useful to select candidates for cardiac resynchronization therapy? Echocardiography is useful before cardiac resynchronization therapy if QRS duration is available. Circ Cardiovasc Imaging. 2008;1:79-84; discussion 84.